NSABP B-39 RTOG 0413

Complete

Return to Protocol Table

Protocol Information

Tab containing protocol details, study design, and eligibility criteria
Tab containing study documents, informed consent forms, and study materials
Tab containing information for potential study participants

A Randomized Phase III Study of Conventional Whole Breast Irradiation (WBI) Versus Partial Breast Irradiation (PBI) for Women with Stage 0, I, or II Breast Cancer

Principal Investigator

Frank A. Vicini

Status

Complete

Date Opened To Accrual

March 21, 2005

Date Closed To Accrual

April 16, 2013

Date of Study Termination

January 31, 2019


Disease Site

Breast [BR] Breast

Phase

III

Developmental Therapeutics

No

Primary Objective

To determine whether partial breast irradiation (PBI) limited to the region of the tumor bed following lumpectomy provides equivalent local tumor control in the breast compared to conventional whole breast irradiation (WBI) in the local management of early stage breast cancer.

Patient Population

Patients with Stage 0, I, or II Breast Cancer Resected by Lumpectomy; Tumor Size ≤ 3.0 cm; No More Than 3 Histologically Positive Nodes

Target Accrual

4214

Patient Study Webpage

There is no available patient study webpage available for this trial at this time.